Software Engineers Lead Drug Breakthough
Summary
Last week the company’s algorithms solved protein folding, a biology riddle that has puzzled researchers for five decades. For perspective, this matches the accuracy of expensive, time consuming laboratory techniques such as nuclear magnetic resonance, x-ray crystallography and cryo-electron microscopy, according to a report at MIT Technology Review. Schrodinger ((SDGR) -Get Report) managers built a cutting edge computational AI and physics-based predictive analytics platform. In the prospectus filed with the Securities and Exchange Commission in January, Schrodinger managers took the unusual step of claiming a big lead over the nearest competitors. However, Bristol Myers Squibb ((BMY) -Get Report) announced in November it would pay $55 million upfront to access Schrodinger’s platform.